Agios Pharmaceuticals Ownership | Who Owns Agios Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Agios Pharmaceuticals Ownership Summary

Agios Pharmaceuticals is owned by 104.33% institutional investors, 1.60% insiders. Farallon capital management is the largest institutional shareholder, holding 9.97% of AGIO shares. BB Biotech AG Ord is the top mutual fund, with 6.16% of its assets in Agios Pharmaceuticals shares.

AGIO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Agios Pharmaceuticals	104.33%	1.60%	-5.94%
Sector	Healthcare Stocks	279.42%	10.64%	-190.05%
Industry	Biotech Stocks	64.05%	10.69%	25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Farallon capital management	5.67M	9.97%	$186.46M
Vanguard group	5.63M	9.89%	$185.05M
Blackrock funding, inc. /de	5.02M	8.81%	$164.83M
Blackrock	4.86M	8.55%	$209.52M
Bellevue group	3.52M	6.17%	$115.51M
Price t rowe associates inc /md/	2.42M	4.26%	$79.64M
Armistice capital	2.26M	3.98%	$74.41M
State street	2.15M	3.78%	$70.72M
Macquarie group	1.68M	2.96%	$55.37M
Geode capital management	1.35M	2.37%	$44.36M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Caligan partners lp	626.28K	5.21%	$20.58M
Cutter capital management, lp	301.62K	4.06%	$9.91M
Eagle health investments lp	330.83K	2.67%	$10.87M
Bellevue group	3.52M	2.22%	$115.51M
Frazier life sciences management	871.97K	1.76%	$37.60M
Patient square capital lp	121.73K	1.50%	$4.00M
Armistice capital	2.26M	1.02%	$74.41M
Farallon capital management	5.67M	0.95%	$186.46M
Centerbook partners lp	305.60K	0.60%	$10.04M
Rock springs capital management lp	471.09K	0.59%	$15.48M

Top Buyers

Holder	Shares	% Assets	Change
Frazier life sciences management	871.97K	1.76%	348.81K
Adage capital partners gp	303.00K	0.02%	303.00K
Deutsche bank ag\	935.25K	0.01%	265.64K
Casdin capital	250.00K	0.55%	250.00K
Blackrock	4.86M	0.00%	200.91K

Top Sellers

Holder	Shares	% Assets	Change
Jefferies financial group	-	-	-1.50M
Bvf inc/il	-	-	-1.07M
T. rowe price investment management	-	-	-928.60K
Vestal point capital, lp	-	-	-760.00K
Jpmorgan chase	1.02M	0.00%	-697.63K

New Positions

Holder	Shares	% Assets	Change	Value
Adage capital partners gp	303.00K	0.02%	303.00K	$9.96M
Casdin capital	250.00K	0.55%	250.00K	$8.21M
Norges bank	145.09K	0.00%	145.09K	$4.77M
Patient square capital lp	121.73K	1.50%	121.73K	$4.00M
Orbimed advisors	26.70K	0.02%	26.70K	$877.36K

Sold Out

Holder	Change
National bank of canada /fi/	-1.00
Global financial private client	-3.00
Ifp advisors	-3.00
Nelson, van denburg & campbell wealth management group	-11.00
Riverview trust	-11.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	223	-4.29%	59,949,912	0.23%	104	0.95%	113	-12.40%	71	2.90%
Dec 31, 2024	231	4.05%	58,738,591	1.40%	103	1.00%	126	22.33%	70	2.94%
Sep 30, 2024	222	1.83%	57,925,704	3.66%	101	1.05%	104	1.96%	66	-15.38%
Jun 30, 2024	218	9.00%	55,883,066	-6.01%	98	0.88%	102	-0.97%	78	39.29%
Mar 31, 2024	200	11.73%	59,453,348	2.90%	105	0.98%	103	9.57%	56	12.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
BB Biotech AG Ord	3.52M	6.16%	-220.76K
Vanguard Total Stock Mkt Idx Inv	1.85M	3.18%	8.48K
Vanguard US Total Market Shares ETF	1.79M	3.12%	2.35K
Macquarie Small Cap Core I	1.54M	2.65%	-
Vanguard Small Cap Index	1.41M	2.43%	-31.98K
Delaware Small Cap Core I	1.38M	2.42%	-8.55K
iShares Russell 2000 ETF	1.36M	2.34%	-21.93K
Polar Capital Biotech S Inc	1.00M	1.73%	-
T. Rowe Price Health Sciences	990.65K	1.71%	-37.30K
Vanguard Institutional Extnd Mkt Idx Tr	895.52K	1.54%	-3.28K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 10, 2025	Scadden David	-	Sell	$56.00K
Jul 09, 2025	Gheuens Sarah	Chief Medical Officer	Sell	$419.77K
Jul 09, 2025	Gheuens Sarah	Chief Medical Officer	Sell	$32.83K
Jul 01, 2025	Gheuens Sarah	Chief Medical Officer	Sell	$139.79K
Jun 24, 2025	Burns James William	Chief Legal Officer	Sell	$93.88K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	3
2025 Q2	-	7
2025 Q1	-	16
2024 Q4	-	9
2024 Q3	-	3

AGIO Ownership FAQ

Who Owns Agios Pharmaceuticals?

Agios Pharmaceuticals shareholders are primarily institutional investors at 104.33%, followed by 1.60% insiders and -5.93% retail investors. The average institutional ownership in Agios Pharmaceuticals's industry, Biotech Stocks , is 64.05%, which Agios Pharmaceuticals exceeds.

Who owns the most shares of Agios Pharmaceuticals?

Agios Pharmaceuticals’s largest shareholders are Farallon capital management (5.67M shares, 9.97%), Vanguard group (5.63M shares, 9.89%), and Blackrock funding, inc. /de (5.02M shares, 8.81%). Together, they hold 28.67% of Agios Pharmaceuticals’s total shares outstanding.

Does Blackrock own Agios Pharmaceuticals?

Yes, BlackRock owns 8.55% of Agios Pharmaceuticals, totaling 4.86M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 209.52M$. In the last quarter, BlackRock increased its holdings by 200.91K shares, a 4.31% change.

Who is Agios Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Caligan partners lp is Agios Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.21% of its assets in 626.28K Agios Pharmaceuticals shares, valued at 20.58M$.

Who is the top mutual fund holder of Agios Pharmaceuticals shares?

BB Biotech AG Ord is the top mutual fund holder of Agios Pharmaceuticals shares, with 6.16% of its total shares outstanding invested in 3.52M Agios Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools